insights_auto
Why is CSBR down 4,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,40 USD
arrow_downward
-4,21%(-0,19) 1D
19-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,47 USD
High
4,47 USD
Low
4,40 USD
Mkt. cap
61,24 млн
Avg. vol.
6,90 миң
Volume
4,87 миң
52-wk high
8,31 USD
52-wk low
4,40 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,47 USD
High
4,47 USD
Low
4,40 USD
Mkt. cap
61,24 млн
Avg. vol.
6,90 миң
Volume
4,87 миң
52-wk high
8,31 USD
52-wk low
4,40 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
FOREX.com
·
7 саат мурун
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
7 саат мурун
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
7 саат мурун
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
5 саат мурун
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com